RAYALDEE

Serial Number 86385790
Registration 4806888
800

Registration Progress

Application Filed
Sep 4, 2014
Under Examination
Approved for Publication
Jun 23, 2015
Published for Opposition
Jun 23, 2015
Registered
Sep 8, 2015

Attorney Assistance

Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2015-09-08)
Due: Sep 08, 2025 62 days

Basic Information

Serial Number
86385790
Registration Number
4806888
Deadline
September 8, 2025
Description
10 Year - Section 8 and 9 Renewal
Filing Date
September 4, 2014
Registration Date
September 8, 2015
Published for Opposition
June 23, 2015
Renewal Date
September 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
May 4, 2025
Registration
Registered
Classes
005

Rights Holder

EIRGEN PHARMA LTD.

99
Address
WESTSIDE BUSINESS PARK
OLD KILMEADEN ROAD
WATERFORD X91 YV67
IE

Ownership History

OPKO Ireland Global Holdings, Ltd.

Original Applicant
99
Grand Cayman KY

OPKO Ireland Global Holdings, Ltd.

Owner at Publication
99
Grand Cayman KY

OPKO Ireland Global Holdings, Ltd.

Original Registrant
99
Grand Cayman KY

EIRGEN PHARMA LTD.

New Owner After Registration #1
99
WATERFORD IE

Legal Representation

Attorney
Richard M. LaBarge

USPTO Deadlines

Next Renewal Deadline
62 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2015-09-08)
Due Date
September 08, 2025
Grace Period Ends
March 08, 2026

Application History

32 events
Date Code Type Description
May 4, 2025 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 4, 2025 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 4, 2025 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
May 4, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 5, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED
Sep 8, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 1, 2021 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Dec 1, 2021 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Dec 1, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 30, 2021 E815 I TEAS SECTION 8 & 15 RECEIVED
Jul 21, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 8, 2020 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 8, 2015 R.PR A REGISTERED-PRINCIPAL REGISTER
Jun 23, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 23, 2015 PUBO A PUBLISHED FOR OPPOSITION
Jun 3, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
May 13, 2015 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 13, 2015 GNEA O EXAMINERS AMENDMENT E-MAILED
May 13, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN
May 13, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED
May 11, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 11, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2015 ALIE A ASSIGNED TO LIE
Apr 30, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2014 GNRT F NON-FINAL ACTION E-MAILED
Dec 19, 2014 CNRT R NON-FINAL ACTION WRITTEN
Dec 16, 2014 DOCK D ASSIGNED TO EXAMINER
Sep 15, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2014 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of diseases and disorders of the parathyroid and renal disease; pharmaceutical preparations for the treatment of hyperparathyroidism; pharmaceuticals for the treatment of secondary hyperparathyroidism; pharmaceutical preparations for the treatment of vitamin D deficiency; nutritional supplements, vitamin supplements

Classification

International Classes
005